Expression and purification of soluble and active human enterokinase light chain in Escherichia coli

Biotechnol Rep (Amst). 2021 May 5:30:e00626. doi: 10.1016/j.btre.2021.e00626. eCollection 2021 Jun.

Abstract

Human enterokinase light chain (hEKL) specifically cleaves the sequence (Asp)4-Lys↓X (D4K), making this a frequently used enzyme for site-specific cleavage of recombinant fusion proteins. However, hEKL production from Escherichia coli is limited due to intramolecular disulphide bonds. Here, we present strategies to obtain soluble and active hEKL from E. coli by expressing the hEKL variant C112S fused with maltose-binding protein (MBP) through D4K and molecular chaperons including GroEL/ES. The fusion protein self-cleaved in vivo, thereby removing the MBP in the E. coli cells. Thus, the self-cleaved hEKL variant was released into the culture medium. One-step purification using HisTrap™ chromatography purified the hEKL variant exhibiting an enzymatic activity of 3.1 × 103 U/mL (9.934 × 105 U/mg). The approaches presented here greatly simplify the purification of hEKL from E. coli without requiring refolding processes.

Keywords: D4K, (Aspartic Acid)4 Lysine; EK, enterokinase; Escherichia coli; Fusion technology; Human enterokinase light chain; IPTG, isopropyl β-D-1-thiogalactopyranoside; MBP, maltose-binding protein; Recombinant protein; Self-cleavage; TEV, tobacco etch virus; bEKL, bovine enterokinase light chain; hEKL, human enterokinase light chain.